|
US5240963A
|
|
Branched polyanhydrides
|
|
US5317079A
|
|
Fatty acid terminated polyanhydride
|
|
WO9305772A1
|
|
φ-[2-(PHOSPHONOALKYL)PHENYL]-2-AMINOALKANOIC ACIDS AS ANTAGONISTS OF EXCITATORY AMINO ACID RECEPTORS
|
|
US5270419A
|
|
Polyanhydrides of oligomerized unsaturated aliphatic acids
|
|
WO9215286A1
|
|
Anti-infective and anti-inflammatory releasing systems for medical devices
|
|
WO9214449A1
|
|
Controlled release microparticulate delivery system for proteins
|
|
US5221535A
|
|
Sustained release formulations of insect repellent
|
|
US5227165A
|
|
Liposphere delivery systems for local anesthetics
|
|
ZA9109196B
|
|
New and useful excitatory amino acid antagonist
|
|
US5188837A
|
|
Lipsopheres for controlled delivery of substances
|
|
US5179189A
|
|
Fatty acid terminated polyanhydrides
|
|
WO9203415A1
|
|
Protein kinase c modulators
|
|
US5189046A
|
|
Protein kinase C modulators
|
|
ZA9103929B
|
|
Sigma binding site agents
|
|
CA2073561A1
|
|
Polyanhydrides of the oligomerized unsaturated aliphatic acids
|
|
AU7182891A
|
|
Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
|
|
IE904098A1
|
|
Lipospheres for controlled delivery of substances
|
|
AU6950091A
|
|
Lipospheres for controlled delivery of substances
|
|
US5135917A
|
|
Interleukin receptor expression inhibiting antisense oligonucleotides
|
|
CA2058925A1
|
|
Pharmaceutical compositions and methods for treating inflammation
|
